In summary, the interplay of HMGB1 release, inflammatory response, and neutrophil extracellular trap generation may be critical for stroke onset and progression, and HMGB1 may serve as a novel target for anti-inflammation and thrombosis, especially in patients with neocoronary stroke. Here, HMGB1 is linked to stroke disorder.